Stem cell guidelines on the way

You can now have your say about regulations on bringing stem cell therapies to the clinic. A special task force set up to create guidelines for bringing stem cell therapies from bench to bedside will be accepting public commentary on the guidelines, continuing until this fall, the group announced today at the annual meeting of the International Society for Stem Cell Research (ISSCR) here in Philadelphia. The task force's primary goals are to create guidelines that will help basic researchers

Written byAndrea Gawrylewski
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share
You can now have your say about regulations on bringing stem cell therapies to the clinic. A special task force set up to create guidelines for bringing stem cell therapies from bench to bedside will be accepting public commentary on the guidelines, continuing until this fall, the group announced today at the annual meeting of the International Society for Stem Cell Research (ISSCR) here in Philadelphia. The task force's primary goals are to create guidelines that will help basic researchers address the regulatory challenges of stem cell therapies. In particular, the task force of more than 30 members from 13 countries will address issues of standardizing stem cell populations -- making sure each line is uncontaminated by others, and that the cells are at a uniform state of differentiation. Similar issues were discussed in April at a linkurl:meeting;http://www.the-scientist.com/blog/display/54544/ of the Food and Drug Administration. But it seems that the ISSCR is no closer to any concrete guidelines than the FDA. Several members of the audience today raised questions about how ISSCR intended to enforce its regulations, what specific terms in the preliminary draft of guidelines mean, and what impact the regulations will have on global regulatory groups. Task force leader linkurl:Olle Lindvall,;http://stemstroke.eu/partners/olle-lindvall from the University of Lund, in Sweden, replied that the group did not yet have the answers. Lindvall said the task force appreciates the FDA's work in parsing out regulating cell-based therapies, but that the ISSCR guidelines are intended to have broader impact and be an international document. You can post comments to the draft guidelines on the ISSCR Web site linkurl:here.;http://www.isscr.org/clinical_trans/index.cfm By the end of the year the task force plans to have a finalized version of the document. With several stem cell-based therapies chomping at the bit to enter clinical trials, let's hope the guidelines appear sooner rather than later.
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

Share
Image of a woman with her hands across her stomach. She has a look of discomfort on her face. There is a blown up image of her stomach next to her and it has colorful butterflies and gut bacteria all swarming within the gut.
November 2025, Issue 1

Why Do We Feel Butterflies in the Stomach?

These fluttering sensations are the brain’s reaction to certain emotions, which can be amplified or soothed by the gut’s own “bugs".

View this Issue
An image of a DNA sequencing spectrum with a radial blur filter applied.

A Comprehensive Guide to Next-Generation Sequencing

Integra Logo
Golden geometric pattern on a blue background, symbolizing the precision, consistency, and technique essential to effective pipetting.

Best Practices for Precise Pipetting

Integra Logo
Olga Anczukow and Ryan Englander discuss how transcriptome splicing affects immune system function in lung cancer.

Long-Read RNA Sequencing Reveals a Regulatory Role for Splicing in Immunotherapy Responses

Pacific Biosciences logo
Research Roundtable: The Evolving World of Spatial Biology

Research Roundtable: The Evolving World of Spatial Biology

Products

Labvantage Logo

LabVantage Solutions Awarded $22.3 Million U.S Customs and Border Protection Contract to Deliver Next-Generation Forensic LIMS

The Scientist Placeholder Image

Evosep Unveils Open Innovation Initiative to Expand Standardization in Proteomics

OGT logo

OGT expands MRD detection capabilities with new SureSeq Myeloid MRD Plus NGS Panel